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Abstract Group sequential trials are one important instance of studies for which the
sample size is not fixed a priori but rather takes one of a finite set of pre-specified val-
ues, dependent on the observed data. Much work has been devoted to the inferential
consequences of this design feature. Molenberghs et al. (Statistical Methods in Med-
ical Research, 2012) and Milanzi et al. (Properties of estimators in exponential family
settings with observation-based stopping rules, 2012) reviewed and extended the exist-
ing literature, focusing on a collection of seemingly disparate, but related, settings,
namely completely random sample sizes, group sequential studies with deterministic
and random stopping rules, incomplete data, and random cluster sizes. They showed
that the ordinary sample average is a viable option for estimation following a group
sequential trial, for a wide class of stopping rules and for random outcomes with a
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distribution in the exponential family. Their results are somewhat surprising in the
sense that the sample average is not optimal, and further, there does not exist an opti-
mal, or even, unbiased linear estimator. However, the sample average is asymptotically
unbiased, both conditionally upon the observed sample size as well as marginalized
over it. By exploiting ignorability they showed that the sample average is the conven-
tional maximum likelihood estimator. They also showed that a conditional maximum
likelihood estimator is finite sample unbiased, but is less efficient than the sample
average and has the larger mean squared error. Asymptotically, the sample average
and the conditional maximum likelihood estimator are equivalent. This previous work
is restricted, however, to the situation in which the the random sample size can take
only two values, N = n or N = 2n. In this paper, we consider the more practically
useful setting of sample sizes in a the finite set {n1, n2, . . . , nL}. It is shown that
the sample average is then a justifiable estimator , in the sense that it follows from
joint likelihood estimation, and it is consistent and asymptotically unbiased. We also
show why simulations can give the false impression of bias in the sample average
when considered conditional upon the sample size. The consequence is that no correc-
tions need to be made to estimators following sequential trials. When small-sample
bias is of concern, the conditional likelihood estimator (CLE) provides a relatively
straightforward modification to the sample average. Finally, it is shown that classical
likelihood-based standard errors and confidence intervals can be applied, obviating
the need for technical corrections.
Keywords Exponential family · Frequentist inference · Generalized sample
average · Joint modeling · Likelihood inference · Missing at random · Sample average
1 Introduction
Principally for ethical and economic reasons, group sequential clinical trials are in
common use [1,9,20,21]. Tools for constructing such designs, and for testing hypothe-
ses from the resulting data, are well established both in terms of theory and imple-
mentation. By contrast, issues still surround the problem of estimation [8,17,19,22]
following such trials. In particular, various authors have reported that standard estima-
tors such as the sample average are biased. In response to this, various proposals have
been made to remove or at least alleviate this bias and its consequences [6,16,18]. An
early suggestion was to use a conditional estimator for this Blackwell [3].
To successfully address the bias issue, it is helpful to understand its origins. Lehman
[11] showed that it stems from the so-called incompleteness of the sufficient statis-
tics involved, which in turn implies that there can be no minimum variance unbiased
linear estimator. Liu and Hall [12] and Liu et al. [13] explored this incompleteness in
group sequential trials, for outcomes with both normal and one-parameter exponential
family distributions. For these distributions, Molenberghs et al. [15] and Milanzi et
al. [14] embedded the problem in the broader class with random sample size, which
includes, in addition to sequential trials, incomplete data, completely random sample
sizes, censored time-to-event data, and random cluster sizes. In so doing, they were
able to link incompleteness to the related concepts of ancillarity and ignorability in the
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missing-data sense. By considering the conventional sequential trial with a determin-
istic stopping rule as a limiting case of a stochastic stopping rule, these authors were
able to derive properties of families of linear estimators as well as likelihood-based
estimators. The key results are as follows: (1) there exists a maximum likelihood esti-
mator (MLE) that conditions on the realized sample size (CL), which is finite sample
unbiased, but has slightly larger variance and mean square error (MSE) than the SA;
(2) the sample average (SA) exhibits finite sample bias, although it is asymptotically
unbiased; (3) apart from the exponential distribution setting, there is no optimal linear
estimator, although the sample average is asymptotically optimal; (4) the validity of
the sample average as an estimator also follows from standard ignorable likelihood
theory.
Evidently, the CL is unbiased both conditionally and marginally with respect to
the sample size. In contrast, the CL is marginally unbiased, but there exist classes of
stopping rules where, conditionally on the sample size, there is asymptotic bias for
some values of the sample sizes. Surprisingly, this is not of concern. Milanzi et al. [14]
showed this for the case of two possible sample sizes, N = n and N = 2n. With such a
stopping rule, it is possible that, for example when N = n, the bias grows unboundedly
with n; when this happens though, the probability that N = n shrinks to 0 at the same
rate. If strict finite sample unbiasedness is regarded as essential, the conditional MLE
can be used, which, like the MLE, also admits the standard likelihood-based precision
measures, although it is computationally intensive. This is a very important result and
should be contrasted with the various precision estimators that have been developed
in the past.
On the other hand, developments in Molenberghs et al. [15] and Milanzi et al.
[14] show that despite finite sample bias, a correction may not be strictly necessary
for SA. Further, its likelihood basis, implies it can be used in conjunction with stan-
dard likelihood-based measures of precision, such as standard errors and associated
confidence intervals to provide valid inferences.
A major limitation of Molenberghs et al. [15] and Milanzi et al. [14] is the restriction
to two looks of equal size. It is the main aim of this paper to extend this work to the
practically more useful setting of multiple looks of potentially different sample sizes.
In Sect. 2, we introduce notation, describe the setting, the models, and the associated
generic problem. In Sect. 3, we study the problems of incompleteness when using a sto-
chastic stopping rule. The class of generalized sample averages in introduced in Sect. 6,
and conditional and joint MLE are derived. Their asymptotic properties are studied in
Sect. 7. A simulation study is described in the Supplementary Materials, Sect. 8.
2 Problem and Model Formulation
Consider a sequential trial with L pre-specified looks, with sample sizes n1 < n2 <
. . . ,< nL . Assume that there are n j i.i.d. observations Y1, . . . , Yn j , from the j th look
that follow an exponential family distribution with density
fθ (y) = h(y) exp {θy − a(θ)} , (1)
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for θ the natural parameter, a(θ) the mean generating function, and h(y) the normal-
izing constant.
Subsequent developments are based on a generic data-dependent stochastic stop-
ping rule, which we write
π(N = n j |kn j ) = F
(
kn j
∣∣ψ) = F (kn j
)
, (2)
where Kn j =
∑n j
i=1 Yi also has an exponential family density:
fn j (k) = hn j (k) exp
{
θkn j − n j a(θ)
}
. (3)
Our inferential target is the parameter θ , or a function of this.
2.1 Stochastic Rule as a Group Sequential Stopping Rule
While the stopping rule seems different from the ones frequently used, it will later on
be clear as to how it can be specified to conform to the commonly used stopping rules
in the sequential trials. For instance, when the conditional probability of stopping of
an exponential family form is chosen, e.g.,
F(kn) = F(k) =
z=A(k)∫
z=−∞
f˜1(z)dz, (4)
then an appealing form for the marginal stopping probability can be derived. Here
f˜1(z) can be seen as an exponential family member, underlying the stopping process.
When the outcomes Y and hence K do not range over the entire real line, the lower
integration limit in (4) should be adjusted accordingly, and the function A(k) should
be chosen so as to obey the range restrictions. It is convenient to assume that f˜1(z)
has no free parameters; should there be the need for such, then they can be absorbed
into A(k). Hence, we can write
f˜1(z) = h˜1(z) exp {−a˜(0)} . (5)
Using (3) and (5), the marginal stopping probability becomes:
P(N = n) =
k=+∞∫
k=−∞
z=A(k)∫
z=−∞
fn,θ (k) f˜1(z)dz dk
= exp {−na(θ) − a˜(0)}
k=+∞∫
k=−∞
hn(k)
⎡
⎣
z=A(k)∫
z=−∞
h˜1(z)dz
⎤
⎦ eθkdk
= exp {−na(θ) − a˜(0)}L {H1(A(k)) · hn(k)} , (6)
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where
H1(t) =
z=t∫
z=−∞
h˜1(z)dz.
Milanzi et al. [14] studied in detail the behavior of stopping rules where
A(k) = α j + βkn j /nmj ,
with α j , β and m are constants specific to a design.
Choosing β → ∞ and β → −∞ results into deterministic stopping or continuing
thus corresponding to the stopping rules commonly used in sequential trials. The trial is
stopped when (6) is greater than a randomly generated number from a Uniform(0,1).
Note that the higher the evidence against (for) the null hypothesis, the higher the
probability to stop. In the specific example of normally distributed responses, (1) can
be chosen as standard normal. The value of α is paramount to deciding the behavior of
stopping boundaries. Consider, for example, O’Brien and Fleming stopping boundaries
where it is difficult to stop in early stages; one can then specify α j such that the
probability of stopping increases with the stages. In addition to the computational
advantages and the associated practicality, we use the stochastic rule to maintain the
focus of this paper, which is estimation.
3 Incomplete Sufficient Statistics
Several concepts play a crucial role in determining the properties of estimators follow-
ing sequential trials: incompleteness, a missing at random (MAR) mechanism, ignora-
bility, and ancillarity [15]. We consider the role of incompleteness first: a statistic s(Y )
of a random variable Y , with Y belonging to a family Pθ , is complete if, for every mea-
surable function g(·), E[g{s(Y )}] = 0 for all θ , implies that Pθ [g{s(Y )} = 0] = 1
for all θ [4, pp. 285–286]. Incompleteness is central to the various developments
[12,13,15] because of the the Lehman-Scheffé theorem which states that “if a statistic
is unbiased, complete, and sufficient for some parameter θ , then it is the best mean-
unbiased estimator (MUE) for θ ,” [4]. In the present setting, the relevant sufficient
statistic is not complete, and so the theorem cannot be applied here.
In line with extending the work of Molenberghs et al. [15] and Milanzi et al. [14] to
a general number of looks, we explore incompleteness and its consequences in studies
with more than two looks, using the stochastic rule.
In a sequential setting, a convenient sufficient statistic is (K , N ). Following the
developments in the above papers, the joint distribution for (K , N ) is:
p(K , N ) = f0(K , N ) F(KN ), (7)
f0(kn1, n1) = fn1(kn1), (8)
f0(kn j , n j ) =
∫
f0(kn j−1 , n j−1) fn j −n j−1(kn j − kn j−1)
[
1 − F(kn j−1)
]
dkn j−1 . (9)
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If (K , N ) were complete, then there would exist a function g(K , N ) such that
E [g(K , N )] = 0 if and only if g(K , N ) = 0, implying that
0 =
∫
g(kn1, n1) fn1(kn1)F(kn1)dkn1 +
L−2∑
j=2
∫
g(kn j , n j )H(kn j )F(kn j )dkn j
+
∫
g(knL , nL)H(knL )F(knL )dknL , (10)
with
H(kn j ) =
⎡
⎣
∫
. . .︸︷︷︸
j−1
∫
f0(kn j−1, n j−1) fn j −n j−1(kn j − kn j−1)
× [1 − F(kn j−1)
]
dkn1 . . . dkn j−1
⎤
⎦ .
Tedious but straightforward algebra results into:
g(knL , nL)H˜(knL ) = −
L−1∑
j=1
∫
g(z j , n j )H˜(z j )F(z j )dz j ,
g(knL , nL) =
∑L−1
j=1
∫
g(z j , n j )H˜(z j )F(z j )dz j
H˜(knL )
.
Assigning, for example, arbitrary constants to g(n1, kn1), . . . , g(nL−1, knL−1), a value
can be found for g(nL , knL ) = 0, contradicting the requirement for (K , N ) to be
complete, hence establishing incompleteness. From applying the Lehmann–Scheffé
theorem, it follows that no best MUE is guaranteed to exist. The practical consequence
of this is that even estimators as simple as a sample average need careful consideration
and comparison with alternatives. Nevertheless, the situation is different for non-linear
mean estimators as illustrated for the CLE.
4 Unbiased Estimation: Conditional Likelihood
An important drawback of linear mean estimators in the context of sequential trials
is their finite-sample bias. In connecting missing data and sequential trials theory,
Molenberghs et al. [15] provided a factorization for the joint distribution of observed
data and sample size that leads to an unbiased conditional likelihood mean estimator.
For an arbitrary number of looks, the conditional distribution for N = n1 is:
fn1(n1, kn1) = fn1(kn1)F(kn1),
fn1(n1) =
∫
fn1(kn1)F(kn1)dkn1 = An1(μ),
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f (kn1 |n1) =
fn1(kn1)F(kn1)
An1(μ)
,
from which the log-likelihood, score, Hessian, and information follow as:
n1(μ) = ln
[
hn1(kn1)
] + θkn1 − n1μ − ln
[
An1(μ)
]
, (11)
Sn1(μ) = kn1 −
Bn1(μ)
An1(μ)
= kn1 − E
[
K
∣∣N = n1
]
, (12)
Hn1(μ) = −
{
Cn1(μ)
An1(μ)
−
(
Bn1(μ)
An1(μ)
)2}
= −
{
E
[
K 2
∣∣N = n1
]
− (E [K ∣∣N = n1
])2}
, (13)
In1(μ) = E
[
K 2
∣∣N = n1
]
− {E [K ∣∣N = n1
]}2
,
where
Bn1(μ) =
∫
kn1 fn1(kn1)dkn1 and Cn1(μ) =
∫
k2n1 fn1(kn1)dkn1 .
Similarly for N = n j where j > 1, we have the conditional distribution:
fn j (n j , kn j ) = H˜(kn j )F(kn j ) exp
[
θkn j − n j a(θ)
]
, (14)
fn j (n j ) =
∫
H˜(kn j )F(kn j ) exp
[
θkn j − n j a(θ)
] = An j (μ), (15)
f (kn j |n j ) =
H˜(kn j )F(kn j ) exp
[
θkn j − n j a(θ)
]
An j (μ)
. (16)
The following expressions for the likelihood, score, Hessian, and information are:
n j (μ) = ln[H˜(kn j )F(kn j )] + θkn j − n jμ − ln An j (μ), (17)
Sn j (μ) = kn j −
Bn j (μ)
An j (μ)
= kn j − E
[
K
∣∣N = n j
]
, (18)
Hn j (μ) = −
⎧
⎨
⎩
Cn j (μ)
An j (μ)
−
[
Bn j (μ)
An j (μ)
]2⎫⎬
⎭
= −
{
E
[
K 2
∣∣N = n j
]
− (E [K ∣∣N = n j
])2}
, (19)
In j (μ) = E
[
K 2
∣∣N = n j
]
− {E [K ∣∣N = n j
]}2
, (20)
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where
Bn j (μ) =
∫
kn j H˜(kn j )F(kn j ) exp(θkn j − n j a(θ))dkn j ,
Cn j (μ) =
∫
k2n j H˜(kn j )F(kn j ) exp(θkn j − n j a(θ))dkn j ( j > 1).
The overall information for the CLE is given by
Ic(μ) =
L∑
j=1
An j (μ)
⎧
⎨
⎩
Cn j (μ)
An j (μ)
−
[
Bn j (μ)
An j (μ)
]2⎫⎬
⎭
,
=
L∑
j=1
n j a′′(θ)An j (μ) −
L∑
j=1
[Bn j (μ) − n j a′(θ)An j (μ)]2
An j (μ)
. (21)
From scores (12) and (18), it can be seen that CLE is unbiased. Clearly, the bias
correction in the CLE mirrors the bias expression of the SA, as can be seen from (33).
Upon writing (12) and (18), as
Sn j (μ) = kn j − n jμ +
[
n jμ −
Bn j (μ)
An j (μ)
]
,
the bias-correction factor in the CLE becomes even more apparent.
In contrast to the case of a fixed sample size, conditioning on the sample size in
this case leads to loss of information, as can be seen by the subtraction of a positive
factor in (21). This is a consequence of conditioning on a non-ancillary statistic, as
discussed in Casella and Berger [4].
Additionally, despite having the appealing property of finite sample unbiasedness,
its non-linear nature comes with computational problems. Note that maximization of
(11) and (14) requires simultaneous optimization and solution of multiple integrals.
Unless small-sample unbiasedness is of paramount importance, consideration has to
be given to the time and complexity of implementing the conditional likelihood.
5 Joint Likelihood Estimation
Likelihood methods, while allowing for a unified treatment across a variety of settings
(e.g., data types, stopping rules), they do rely heavily on correct parametric specifica-
tion. This should be taken into account when opting for a particular approach.
Selection model factorization for the joint distribution of observed data and sample
size also leads to joint likelihood estimation (JLE). Employing the separability and
ignorability concepts from the missing data theory, it is known that under a missing at
random (MAR) assumption, maximizing the joint likelihood is equivalent to maximiz-
ing the likelihood of the observed data only. This is crucial when considered against
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the background of Kenward and Molenberghs [10], where it was shown that for fre-
quentist inference and under the MAR assumption, the observed information matrix
gives valid inferences. Other properties of joint likelihood estimation are explored
below.
The joint distribution of the sufficient statistics (K , N ) is given by:
f (K , N ) = hN (K ) exp [K θ − Na(θ)] ·
L−1∏
i=1
[
1 − F(kn j )
]
F(knL )I (i<L). (22)
Because our stopping rule is independent of the parameter of interest, the log-
likelihood, the score, the Hessian, and the expected information simplify as follows:
(μ) = ln[hN (K )]+K θ − Na(θ)+ln
{L−1∏
i=1
[
1−F(kn j )
]
F(knL )I (i<L)
}
, (23)
S(μ) = K − Na′(θ), (24)
H(μ) = −Na′′(θ), (25)
I (μ) =
L∑
j=1
n j a′′(θ)An j (μ). (26)
In deriving the score (24) from (23) the rightmost term drops out, i.e., conventional
ignorability applies. As a consequence, the MLE reduces to μ̂ = a′(θ) = K/N , the
SA.
Because of the bias, a finite sample comparison among estimators needs to be based
on the MSE. For μ̂, this is
MSE(μ̂) = 1∑L
j=1 n j a′′(θ)An j (μ)
+
⎡
⎣
L∑
j=1
[
Bn j (μ) − An j n jμ
]
n j
⎤
⎦
2
. (27)
For the CLE the MSE is:
MSE(μ̂c) = 1Ic(μ) =
1
∑L
j=1 n j a′′(θ)An j (μ)
+ y[∑L
j=1 n j a′′(θ)An j (μ)
]2 − y ∑Lj=1 n j a′′(θ)An j (μ)
,
(28)
where
y =
L∑
j=1
[
Bn j (μ) − An j n j (μ)
]2
An j (μ)
.
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The condition that MSE(μ̂) ≥ MSE(μ̂c) is equivalent to the requirement that
⎡
⎣
L∑
j=1
[
Bn j (μ) − An j n jμ
]
n j
⎤
⎦
2
≥ 1∑L
j=1 n j a′′(θ)An j (μ)
holds. For the special case of equal sample sizes this can never be true, hence the SA
has the smaller MSE. More generally, neither is uniformly superior in terms of MSE.
6 Generalized Sample Averages
To get a broad picture of the properties of the SA, which follows from JLE, we embed
it into a broader class of linear estimator. Extending the definition in Molenberghs et
al. [15], the generalized sample average (GSA) can be be defined as:
μ¯g =
L∑
j=1
a j
n j
kn j , (29)
for a set of constants a1, . . . , aL . The SA follows as the special case where each
a j = 1. To explore the properties of the GSA, we make use of the fact that:
∫
fn1(kn1)dkn1 +
L∑
j=2
∫
H˜(kn j )F(kn j ) exp(θkn j − n j a(θ))dkn j = 1,
and derive three useful identities:
∫
fn1(kn1)dkn1 = 1 −
L∑
j=2
An j (μ), (30)
L∑
j=1
Bn j (μ) =
L∑
j=1
n j a′(θ)An j (μ), (31)
L∑
j=1
Cn j =
L∑
j=1
2n j a′(θ)Bn j (μ) − [n j a′(θ)]2 An j (μ) + n j a′′(θ)An j (μ).
Using identities (30) and (31), the expectation of (29) can then be formulated as
E
[
μ¯g
] = a1
n1
Bn1(μ) +
L∑
j=2
a j
n j
Bn j (μ) = a1μ
+
L∑
j=2
a1 An j (μ)
n1 − n j
n1
[
n1a j − n j a1
a1(n1 − n j ) E
{
K
N
∣∣
∣∣N = n j
}
− μ
]
, (32)
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establishing the bias as a function of the difference between the marginal and condi-
tional means. When (32) is unbiased, at least one value among a1, . . . , aL will depend
on μ. This means that none of the GSA can be uniformly unbiased. Focusing on the
SA, the expectation reduces to
E [μ¯] = μ +
L∑
j=2
An j (μ)
n1 − n j
n1
[ Bn j (μ)
n j An j (μ)
− μ
]
= μ +
L∑
j=2
An j (μ)
n1 − n j
n1
[
E
{
K
N
∣∣∣
∣N = n j
}
− μ
]
, (33)
from which we get the bias as
L∑
j=2
An j (μ)
n1 − n j
n1
[ Bn j (μ)
n j An j (μ)
− μ
]
=
L∑
j=2
n1 − n j
n1n j
[
Bn j (μ) − An j n jμ
]
=
L∑
j=1
[
Bn j (μ) − An j n jμ
]
n j
. (34)
Thus, the SA is unbiased when the conditional and marginal means are equal.
7 Asymptotic Properties
We now turn to the large-sample properties of the estimators discussed in the previ-
ous sections. When N → ∞, approximately K ∼ N (Nμ, Nσ 2), so normal-theory
arguments can be used. Considering a first-order Taylor series expansion of F(kn j )
around n jμ results in F(kn j ) ≈ F(n jμ) + F ′(n jμ)(kn j − n jμ). Without loss of
generality, consider a class of stopping rules for which F ′(n j )
n→∞→ 0. In this setting,
the expressions derived above can be approximated by
An1(μ) ≈ F(n1μ),
Bn1(μ) ≈ F(n1μ)n1μ,
An j (μ) ≈
j−1∏
i=1
[1 − F(niμ)]F(n jμ), ( j > 1)
Bn j (μ) ≈
j−1∏
i=1
[1 − F(niμ)]F(n jμ)n jμ, ( j > 1).
These approximations will be useful in what follows.
123
Stat Biosci
7.1 Asymptotic Bias
7.1.1 Conditional Likelihood Estimation
We turn now to the asymptotic conditional behavior of the bias of the sample average
given the sample size. Two cases are considered:
Case I F(nμ) n→∞−→ a ∈]0, 1[ and F ′(nμ) n→∞−→ 0. For this case E[μ¯|N =
n j ] n→∞−→ μ, for j = 1, . . . , L .
Case II Here, both the function F(·) and its first derivative F(·) converge to zero.
When this happens, it does so for all but one of the sample sizes that can possibly be
realized. The one exception is the sample size that will be realized, asymptotically,
with probability one. Without loss of generality, we illustrate this case for stopping
at the first look, assuming that the sample size realized at the first look corresponds
to a set of values for μ that do not contain the true one. Thus, F(nμ) n→∞−→ 0
and F ′(nμ) n→∞→ 0. This case can correspond for particular forms of F(kn j ).
Given that K is asymptotically normally distributed, letting F(K ) = (k) is a
mathematically convenient choice from which it follows that F(n jμ) = Φ(n jμ).
Consider first N = n1. Then,
lim
n1→∞
E[μ¯|N = n1] = μ − lim
n1→∞
φ(n1μ)σ 2
Φ(n1μ)
,
of which the right hand term approaches 0/0. We therefore apply l’Hopital’s rule
and obtain:
lim
n1→∞
E[μ¯|N = n1] = μ − lim
n1→∞
−n1μφ(n1μ)
φ(n1μ)
→ ∞,
with the sign opposite to that of μ. Hence, conditional on the fact that stopping
occurs after the first look, the estimate may grow in an unbounded way. However,
recalling that F(nμ), the probability of stopping when N = n1, also approaches
zero, these extreme estimates are a the same time also extremely rare. In the same
case, for N = n j ( j > 1), limn→∞ E[μ¯|N = n j ] → μ. So for these sample sizes
no asymptotic bias occurs.
Milanzi et al. [14] showed that a large class of stopping rules corresponds to either
Case I or Case II. For example, for stopping rule Φ(α + βk/n), they found that
Case I applies. Switching to Φ(α + βk), F ′(nμ) = βφ(α + βnμ) which again tends
to zero. However, Φ(α + βnμ) may tend to either zero or one. For a general rule
F(k) = Φ(α + βknm), with m any real number, F ′(nμ) converges to zero whatever
m is. Further, F(nμ) converges to Φ(α + βμ) for m = −1, Φ(α) for m < −1, and
Φ(±∞) (i.e., 0 or 1) for m > −1.
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7.1.2 Joint Likelihood Estimation
Recall that the bias for the SA was given by (34), which asymptotically tends to the
limit
lim
n→∞
L∑
j=1
∏ j−1
i=1 [1 − F(niμ)]F(n jμ)n jμ −
∏ j−1
i=1 [1 − F(niμ)]F(n jμ)n jμ
n j
−→ 0.
Although the sample average is generally finite-sample biased for data-dependent
stopping rules, it is asymptotically unbiased and hence can be considered an appropri-
ate candidate for practical use following a sequential trial. Emerson [5] established the
same result for two possible looks and further noted that this property is not relevant
in group sequential trials, because large sample sizes are unethical, hence making the
study of small sample properties crucial. On the other hand, results from a compre-
hensive analysis, comparing randomized controlled trials (RCTs) stopped for early
benefit (truncated) and RCTs not stopped for early benefit (non-truncated), indicated
that treatment effect was over-estimated in most of truncated RCTs regardless of the
pre-specified stopping rule used [2]. They further advocate stopping rules that demand
large number of events. In their exploration of properties of estimators, Milanzi et al.
[14] showed that in the general class of linear mean estimators, only the sample average
has the asymptotic unbiasedness property, thus giving it an advantage in cases where
asymptotic unbiasedness would play a role. The sample average is asymptotically
unbiased in all cases, and additionally conditionally asymptotically unbiased, even in
the case of an arbitrary number of looks. Further, under the usual likelihood regularity
conditions, the SA is then consistent and asymptotically normally distributed, and the
likelihood-based precision estimator and its corresponding confidence intervals are
valid. Care has to be exercised when working under the MAR assumption, as is the
case here, because the observed information matrix rather than the expected infor-
mation matrix should be used to obtain precision estimators to ensure their validity.
Kenward and Molenberghs [10] noted that, provided that use is made of the likelihood
ratio, Wald, or score statistics based on the observed information, then reference to a
null asymptotic χ2 distribution will be appropriate.
This conventional asymptotic behavior contrasts with the idiosyncratic small-
sample properties of the SA derived in Sect. 6.
7.2 Asymptotic Mean Square Error
Given that the bias for the sample average tends to zero as the sample size increases
and that
∑L
j=1 Bn j (μ) − An j (μ)n jμ n→∞−→ 0, it follows that
lim
n→∞ MSE(μ̂) = limn→∞ MSE(μ̂c) →
1
∑L
j=1 n j a′′(θ)An j (μ)
.
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8 Simulation Study
8.1 Design
The simulation study has been designed to corroborate the theoretical findings on the
behavior of the likelihood estimators, in comparison to commonly used biased adjusted
estimators. Assume a clinical trial comparing a new therapy to a control, designed to
follow O‘Brien and Fleming’s group sequential plan with four interim analyses.
The objective of the trial is to show that the mean response from the new therapy
is higher than that of the control group. Let Yit ∼ N (μt , 1) and Yic ∼ N (μc, 1)
be the responses from subject i in the therapy and control groups, respectively. The
null hypothesis is formulated as H0 : θ = μt − μc = 0 versus H1 : θ = θ1 > 0.
Further, allow a type I error of 2.5 and 90 % power to detect the clinically meaningful
difference.
Given that we are interested in asymptotic behavior, different values of the clinically
meaningful difference, θ1 = 0.5, 0.25, and 0.15 are considered to achieve different
sample sizes, with smaller θ1 corresponding to larger sample size.
With the settings described above, datasets are generated as follows; at each stage,
Yit ∼ N (2, 1), i = 1 . . . n j , j = 1 . . . 4 and Yic ∼ N (μc, 1), where μc = 1.5, 1.75,
and 1.85 for the first, second, and third setting, respectively. These also serve as the
true mean values under which the bias is being considered.
Estimation proceeds by obtaining the MLE (sample average: μ̂t − μ̂c) at each stage
and applying the stopping rule:
F(kn j ) = Φ
(
α j + β k j
n j
)
, ( j = 1 . . . 4),
where β = 100 to represent the rules applied to the group sequential trials case [14].
To follow the behavior of O’Brien and Fleming boundaries (where early stopping
is difficult), a value of α is chosen to make sure that the probability of stopping
increases with the increase in number of looks, i.e., α j = [2(h − j + 1)]/hα1, where
α1 = −50, −25, and −15, for θ1 = 0.5, 0.25, and 0.15, respectively, and h is the
number of planned looks. Obviously, the choice of α j depends on the design and goals
of the trial. In this setting, α1 was chosen such that P(N = n3|θ = θ1) ≥ 0.5 and to
make early stopping difficult. The decision to stop is made when F(kn j ) > U , where
U ∼ Uniform(0, 1); otherwise, we continue. For example if F(kn j ) = 0.70, then the
probability of continuing is 30 % and for large values of β, F(kn j ) ∈ {0, 1}.
The objective of the simulation is to show that the performance of the CLE as the
mean estimator after a group sequential trial and compare MLE to other bias adjusted
estimators (BAM). We further show that MLE confidence intervals obtained by using
the observed information matrix, lead to valid conclusions.
Other estimators obtained include: the MUE (MUE), the bias adjusted estimator
(BAM; Todd et al. [19]), and Rao’s bias-adjusted estimator (RBADJ; Emerson and
Fleming [6]).
Additional simulations with two possible looks and a smaller value of β for both
joint and conditional likelihood are presented in the Appendix.
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Table 1 Mean estimates (Est.) and relative bias (R. Bias) for the three different settings of O’Brien and
Fleming’s design
MLE BAM RBADJ MUE CLE
Size Est. R.Bias Est. R.Bias Est. R.Bias Est. R.Bias Est. R.Bias
176 0.5448 (0.0895) 0.5142 (0.0285) 0.5019 (0.0037) 0.5251 (0.0502) 0.5026 (0.0052)
702 0.2665 (0.0661) 0.2508 (0.0031) 0.2473 (0.0108) 0.2557 (0.0228) 0.2476 (0.0094)
1949 0.1595 (0.0635) 0.1489 (0.0070) 0.1469 (0.0209) 0.1520 (0.0130) 0.1511 (0.0071)
Parameters common to all the three settings include, power = 90 %, type I error = 0.025, H0 : θ = 0 versus
H1 : θ = θ1 > 0, where only the detectable difference (θ1) was changed to initiate change in maximum
sample size (Size). MLE is the maximum likelihood estimate, BAM is the bias-adjusted maximum likelihood
estimator, RBADJ is the Rao bias-adjusted estimator, MUE is the median unbiased estimator, and CLE is
the conditional likelihood estimator
8.2 Results
Table 1 gives the mean estimates for different estimators of θ . On average, the MLE
exhibits large relative bias compared to the BAM, for example, for θ1 = 0.15, which
corresponds to a maximum sample size of 1949, relative bias for MLE is 6 % compared
to 0.7 % for CLE. The CLE performs as expected with consistently small bias under
all the three scenarios. On the other hand, the MLE shows asymptotically unbiased
behavior, seen by the reduction (though small) in relative bias as sample size increases.
This is not the same for BAM and RBADJ.
While point estimates are useful in giving the picture of the magnitude of the
difference, confidence intervals (CI) are highly important in decision making. A com-
parison of adjusted confidence intervals provided with the RCTdesign package in R
[7], to the likelihood based confidence intervals, obtained by using observed variance
as precision estimates, indicates that their coverage probabilities are comparable. The
coverage probabilities were (94.6, 94.6, 97.6 %) for the adjusted CI and (93.8, 92.8,
96.8 %) for MLE based CI, for the three settings in the order of increasing sample
size. Using the same design parameters, we also investigated the type I error rate for
MLE and adjusted estimators, by setting θ1 = 0 and obtaining the percentage times
the confidence interval does not contain zero. Type I error rates for likelihood based
CI were (5.6, 6.4, 2.8 %), which are similar to those based on adjusted CIs, (5.4, 4.8,
2.8 %) for the three settings in the order of increasing sample size. Certainly, using
either of the CIs will lead to similar conclusions, which makes the simpler and well
known sample average a good estimator candidate for analysis after group sequential
trials.
At first sight, it looks like there may be less practical interest, given this similarity.
However, the implications should not be underestimated. There is a general feeling
that adjustments need to be made. As is clear from earlier work in the literature and
from this manuscript, corrections are computationally challenging. In contrast, the
standard joint likelihood estimator being the ordinary sample average, is extremely
simple. Thus, our results may simplify calculations in important ways.
We also explore the bias of each of the estimators at the sample level in contrast
to the averaged bias as presented in Table 1. Recall that we had 500 samples for each
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Table 2 Results from three different settings of O’Brien and Fleming’s design
θ1 (Size) R.Bias(%) Prop.(%) BAM RBADJ MUE MLE CLE
0.5 (176) ≤ 0.99 2.6 2.0 2.2 2.2 76.3
1 − 4.99 8.4 11.4 11.0 10.6 13.2
5 − 10 10.6 11.6 12.6 15.0 7.9
> 10 78.4 75.0 74.2 72.2 2.6
0.25 (702) ≤ 0.99 2.0 3.2 1.4 2.6 81.3
1 − 4.99 7.2 9.0 8.8 9.0 12.5
5 − 10 9.4 9.8 10.8 9.8 2.1
> 10 81.4 78.0 79.0 78.6 4.2
0.15 (1949) ≤ 0.99 2.6 1.8 1.4 2.2 55.6
1 − 4.99 7.4 13.2 8.0 13.2 33.3
5 − 10 9.2 9.0 11.8 11.0 8.9
> 10 80.8 76.0 77.6 74.4 2.2
Parameters common to all three settings include: power = 90 %, type I error = 0.025, H0 : θ = 0 versus
H1 : θ = θ1 > 0, where only the detectable difference (θ1) was changed to initiate change in maximum
sample size (Size). Out of 500 datasets generated for each setting, we compare the percentage of estimates
(Prop. as a percentage) whose relative bias falls in the specified range (R.Bias as a percentage)
MLE is the maximum likelihood estimate, BAM is the biased adjusted maximum likelihood estimator,
RBADJ is Rao’s bias-adjusted estimator, MUE is the median unbiased estimator, and CLE is the conditional
likelihood estimator
setting, Table 2 gives the proportion of samples whose estimates’ relative bias fell into
a specified category. The CLE had a reverse trend of the other estimators where a only
few estimated had large bias. Indeed, it is hard to pick a preferred estimator among
the others estimators based on these results since each of the estimator has about 75 %
of the estimates having relative bias of >10 %. It is also clear from Fig. 1, which plot
the difference in relative bias, between each of the BAM and MLE, that none of the
estimates discussed above is uniformly unbiased in comparison to MLE, i.e is some
instances MLE may do better.
9 Concluding Remarks
As a result of the bias associated with joint maximum likelihood estimators following
sequential trials, much work has been applied to providing alternative estimators. The
origin of the problem lies with the incompleteness of the sufficient statistic for the
mean parameter [11], implying, among others, that there is no best MUE.
Using stochastic stopping rules, which encompass the deterministic stopping rules
used in sequential trials as special cases, we have studied the properties of joint max-
imum likelihood estimators afresh, in an attempt to enhance our understanding of the
behavior of estimators (for both bias and precision) based on data from such studies.
We have focused on one-parameter exponential family distributions, which encom-
passes several response types, including but not limited to binary, normal, Poisson,
exponential, and time-to-event data.
First, the incompleteness of the sufficient statistic when using a stochastic stopping
rule has been established. Using a GSA, it is noted that in almost no case is there
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Fig. 1 Difference in relative bias between MLE and each the biased adjusted estimates (BAM, RBADJ
and MUE). The first row is for θ1 = 0.5, second row, θ1 = 0.25 and third row, |
an unbiased estimator. Even when such an estimator does exist, with a completely
random sample size, it cannot be uniformly best.
Second, there exist an unbiased estimator resulting from the likelihood of the
observed data conditional on the sample size. While appealing, the conditional esti-
mator is computationally more involved, because there is no closed-form solution.
Although for a sequential trial with a deterministic stopping rule, the ordinary sample
average is finite-sample biased, it can be been shown both directly and through like-
lihood arguments, that it is asymptotically unbiased and so remains a good candidate
for practical use. Further, it is computationally trivial, has a correspondingly simple
estimator of precision, derived from the observed information matrix and hence a well
behaved asymptotic likelihood-based confidence interval. In addition, the mean square
error of the sample average is smaller than that of the estimator based on the conditional
likelihood. Asymptotically, the mean square errors of both estimators converge.
Third, there is the subtle issue that the sample average may be asymptotically biased
for certain stopping rules, when its expectation is considered conditionally on certain
values of the sample size. However, this is not a real practical problem because this
occurs only for sample sizes that have asymptotic probability zero of being realized.
We placed emphasis on joint and CLE. While in the former the stopping rule is less
present than sometimes thought, it is not in the latter. Also, when alternative frequentist
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estimators are considered, the stopping rule is likely to play a role in synchrony with
the rule’s influence on hypothesis testing due to the duality between hypothesis testing
and confidence intervals.
While in some circumstances other sources of inaccuracy may overwhelm the issue
studied here, we believe that it is useful to bring forward implications of our findings
for likelihood-based estimation.
Our findings, especially for the simulations in the Appendix, indicate that bias
decreases relatively rapidly with sample size, but there are subtle differences depending
on stopping rule considered. In this sense, fixed rules are different from Z -statistic
based rules [5, p. 5], [9].
In conclusion, the sample average is a very sensible choice for point, precision, and
interval estimation following a sequential trial.
Acknowledgments Elasma Milanzi, Geert Molenberghs, Michael G. Kenward, and Geert Verbeke grate-
fully acknowledge support from IAP research Network P7/06 of the Belgian Government (Belgian Science
Policy). The work of Anastasios Tsiatis and Marie Davidian was supported in part by NIH grants P01
CA142538, R37 AI031789, R01 CA051962, and R01 CA085848.
References
1. Armitage P (1975) Sequential medical trials. Blackwell, Oxford
2. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansedell D, Walter SD, Guyatt
GH (2010) Stopping randomized trials early for benefit and estimation of treatment effects. Systematic
review and meta-regression analysis. J Am Med Assoc 303:1180–1187
3. Blackwell D (1947) Conditional expectation and unbiased sequential estimation. Ann Math Stat
18:105–110
4. Casella G, Berger RL (2001) Statistical inference. Duxbury Press, Pacific Grove
5. Emerson SS (1988) Parameter estimation following group sequential hypothesis testing. PhD disser-
tation. University of Washington
6. Emerson SS, Fleming TR (1990) Parameter estimation following group sequential hypothesis testing.
Biometrika 77:875–892
7. Emerson SS, Gillen DL, Kittelson JK, Emerson SC, Levin GP (2012) RCTdesign: group sequential
trial design. R package version 1
8. Hughes MD, Pocock SJ (1988) Stopping rules and estimation problems in clinical trials. Stat Med
7:1231–1242
9. Jennison C, Turnbull BW (2000) Group sequential methods with applications to clinical trials. Chapman
& Hall/CRC, London
10. Kenward MG, Molenberghs G (1998) Likelihood based frequentist inference when data are missing
at random. Stat Sci 13:236–247
11. Lehmann EL, Stein C (1950) Completeness in the sequential case. Ann Math Stat 21:376–385
12. Liu A, Hall WJ (1999) Unbiased estimation following a group sequential test. Biometrika 86:71–78
13. Liu A, Hall WJ, Yu KF, Wu C (2006) Estimation following a group sequential test for distributions in
the one-parameter exponential family. Stat Sin 16:165–181
14. Milanzi E, Molenberghs G, Alonso A, Kenward MG, Aerts M, Verbeke G, Tsiatis AA, Davidian M
(2012) Properties of estimators in exponential family settings with observation-based stopping rules
(under review)
15. Molenberghs G, Kenward MG, Aerts M, Verbeke G, Tsiatis AA, Davidian M, Rizopoulos D (2014) On
random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential
trials, random sample sizes, and missing data. Stat Method Med Res 23:11–41
16. Rosner GL, Tsiatis AA (1988) Exact confidence intervals following a group sequential trial: a com-
parison of methods. Biometrika 75:723–729
17. Siegmund D (1978) Estimation following sequential tests. Biometrika 64:191–199
123
Stat Biosci
18. Tsiatis AA, Rosner GL, Mehta CR (1984) Exact confidence intervals following a group sequential test.
Biometrics 40:797–803
19. Todd S, Whitehead J, Facey KM (1996) Point and interval estimation following a sequential clinical
trial. Biometrika 83:453–461
20. Wald A (1945) Sequential tests of statistical hypotheses. Ann Math Stat 16:117–186
21. Whitehead J (1997) The design and analysis of sequential clinical trials, 2nd edn. Wiley, New York
22. Whitehead J (1999) A unified theory for sequential clinical trials. Stat Med 18:2271–2286
123
